vs
Side-by-side financial comparison of ALLIANCE ENTERTAINMENT HOLDING CORP (AENT) and Bio-Techne (TECH). Click either name above to swap in a different company.
ALLIANCE ENTERTAINMENT HOLDING CORP is the larger business by last-quarter revenue ($368.7M vs $295.9M, roughly 1.2× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 2.5%, a 10.3% gap on every dollar of revenue. On growth, ALLIANCE ENTERTAINMENT HOLDING CORP posted the faster year-over-year revenue change (-6.3% vs -6.4%). Over the past eight quarters, ALLIANCE ENTERTAINMENT HOLDING CORP's revenue compounded faster (32.1% CAGR vs 4.2%).
Alliance Atlantis Communications Inc. was a media company that operated primarily as a specialty service provider in Canada. Primarily based in Toronto, Alliance Atlantis also had offices in Halifax, Los Angeles, London, Dublin, Madrid, Barcelona, Shannon, and Sydney.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
AENT vs TECH — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $368.7M | $295.9M |
| Net Profit | $9.4M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 4.7% | 18.4% |
| Net Margin | 2.5% | 12.8% |
| Revenue YoY | -6.3% | -6.4% |
| Net Profit YoY | 32.8% | 68.3% |
| EPS (diluted) | $0.18 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $368.7M | $295.9M | ||
| Q3 25 | $254.0M | — | ||
| Q2 25 | $227.8M | $317.0M | ||
| Q1 25 | $213.0M | $316.2M | ||
| Q4 24 | $393.7M | $297.0M | ||
| Q3 24 | $229.0M | $289.5M | ||
| Q2 24 | $236.9M | $306.1M | ||
| Q1 24 | $211.2M | $303.4M |
| Q4 25 | $9.4M | $38.0M | ||
| Q3 25 | $4.9M | — | ||
| Q2 25 | $5.8M | $-17.7M | ||
| Q1 25 | $1.9M | $22.6M | ||
| Q4 24 | $7.1M | $34.9M | ||
| Q3 24 | $397.0K | $33.6M | ||
| Q2 24 | $2.5M | $40.6M | ||
| Q1 24 | $-3.4M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 4.7% | 18.4% | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 4.3% | -7.5% | ||
| Q1 25 | 1.7% | 12.2% | ||
| Q4 24 | 3.8% | 16.0% | ||
| Q3 24 | 0.9% | 13.8% | ||
| Q2 24 | 0.2% | 15.0% | ||
| Q1 24 | -0.3% | 22.1% |
| Q4 25 | 2.5% | 12.8% | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 2.5% | -5.6% | ||
| Q1 25 | 0.9% | 7.1% | ||
| Q4 24 | 1.8% | 11.7% | ||
| Q3 24 | 0.2% | 11.6% | ||
| Q2 24 | 1.1% | 13.3% | ||
| Q1 24 | -1.6% | 16.2% |
| Q4 25 | $0.18 | $0.24 | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $0.11 | $-0.11 | ||
| Q1 25 | $0.04 | $0.14 | ||
| Q4 24 | $0.14 | $0.22 | ||
| Q3 24 | $0.01 | $0.21 | ||
| Q2 24 | $0.05 | $0.26 | ||
| Q1 24 | $-0.07 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $117.6M | $2.0B |
| Total Assets | $434.1M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | $4.3M | $187.5M | ||
| Q2 24 | $1.1M | $152.9M | ||
| Q1 24 | $1.6M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $117.6M | $2.0B | ||
| Q3 25 | $108.1M | — | ||
| Q2 25 | $103.2M | $1.9B | ||
| Q1 25 | $97.4M | $2.0B | ||
| Q4 24 | $95.6M | $2.1B | ||
| Q3 24 | $88.0M | $2.1B | ||
| Q2 24 | $87.6M | $2.1B | ||
| Q1 24 | $85.1M | $2.0B |
| Q4 25 | $434.1M | $2.5B | ||
| Q3 25 | $383.0M | — | ||
| Q2 25 | $361.2M | $2.6B | ||
| Q1 25 | $349.4M | $2.6B | ||
| Q4 24 | $401.7M | $2.7B | ||
| Q3 24 | $395.7M | $2.7B | ||
| Q2 24 | $340.8M | $2.7B | ||
| Q1 24 | $324.0M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.5M | — |
| Free Cash FlowOCF − Capex | $-16.9M | — |
| FCF MarginFCF / Revenue | -4.6% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | -1.76× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.5M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $10.7M | $98.2M | ||
| Q1 25 | $2.5M | $41.1M | ||
| Q4 24 | $25.3M | $84.3M | ||
| Q3 24 | $-11.6M | $63.9M | ||
| Q2 24 | $9.7M | $75.5M | ||
| Q1 24 | $20.0M | $81.0M |
| Q4 25 | $-16.9M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $10.7M | $93.3M | ||
| Q1 25 | $2.4M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $-11.6M | $54.7M | ||
| Q2 24 | — | $57.5M | ||
| Q1 24 | $20.0M | $64.5M |
| Q4 25 | -4.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 4.7% | 29.4% | ||
| Q1 25 | 1.1% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | -5.1% | 18.9% | ||
| Q2 24 | — | 18.8% | ||
| Q1 24 | 9.4% | 21.3% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.0% | 3.2% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | 0.0% | 5.4% |
| Q4 25 | -1.76× | — | ||
| Q3 25 | 0.56× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | 1.33× | 1.82× | ||
| Q4 24 | 3.57× | 2.42× | ||
| Q3 24 | -29.31× | 1.90× | ||
| Q2 24 | 3.85× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AENT
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
